Head to Head Survey: Senseonics (SENS) and Its Rivals

Senseonics (NASDAQ:SENS) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its peers? We will compare Senseonics to related businesses based on the strength of its risk, valuation, dividends, analyst recommendations, institutional ownership, profitability and earnings.

Insider & Institutional Ownership

12.4% of Senseonics shares are owned by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 4.7% of Senseonics shares are owned by insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Senseonics and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Senseonics	-204.01%	-186.11%	-86.21%
Senseonics Competitors	-303.57%	-175.14%	-22.20%

Analyst Ratings

This is a breakdown of recent recommendations for Senseonics and its peers, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Senseonics	1	3	3	0	2.29
Senseonics Competitors	4295	10584	18370	832	2.46

Senseonics currently has a consensus target price of $14.40, indicating a potential upside of 43.43%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.31%. Given Senseonics’ higher probable upside, equities analysts plainly believe Senseonics is more favorable than its peers.

Volatility and Risk

Senseonics has a beta of 1.04, indicating that its stock price is 4% more volatile than the S&P 500. Comparatively, Senseonics’ peers have a beta of 2.57, indicating that their average stock price is 157% more volatile than the S&P 500.

Valuation & Earnings

This table compares Senseonics and its peers top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Senseonics	$35.26 million	-$69.11 million	-4.37
Senseonics Competitors	$1.87 billion	$137.20 million	5.88

Senseonics’ peers have higher revenue and earnings than Senseonics. Senseonics is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Summary

Senseonics peers beat Senseonics on 10 of the 12 factors compared.

Senseonics Company Profile

Senseonics Holdings, Inc. develops continuous glucose monitoring (CGM) technology for people with diabetes. Its Eversense systems use a small sensor implanted under the skin to measure glucose levels, an external wearable transmitter to send readings, and a mobile app to display data and provide alerts. The company’s product line includes implantable CGM systems designed for extended wear, including the Eversense 365 system, which is designed to last up to one year. Unlike many CGM products that use sensors replaced more frequently, Eversense sensors are inserted and removed by a healthcare professional.